Ancora Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

Ancora Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	500	–	–	﹤0.01%	2448
2026 Q1	$5	Hold	500	–	–	﹤0.01%	2381
2025 Q4	$0	Hold	500	–	–	﹤0.01%	2552
2025 Q3	$0	Buy	+500	New	–	﹤0.01%	2112

Ancora Advisors's ACUR Position: Q2 2026 in Review

Ancora Advisors held its Acura Pharmaceuticals (ACUR) position steady in Q2 2026 at 500 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

Ancora Advisors first reported a position in ACUR in Q3 2025 and has held it in 4 quarters since. The position peaked at $5 in Q1 2026. 1 fund tracked by Wall St. Rank holds ACUR as of Q2 2026.

Ancora Advisors held 500 shares of Acura Pharmaceuticals worth $0 as of Q2 2026.
Ancora Advisors left its Acura Pharmaceuticals share count unchanged in Q2 2026.
Acura Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #2448 holding.
Ancora Advisors first reported a position in Acura Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
Ancora Advisors's Acura Pharmaceuticals position peaked at $5 in Q1 2026.
1 fund tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.